S&P 500 Healthcare Sector SEC Filings — April 09, 2026

09-04-2026

Ensysce Biosciences filed an S-3 shelf registration statement on April 8, 2026, allowing Selling Securityholders to sell common stock, with the company receiving no proceeds but potential funds from warrant exercises for working capital. The company reports substantial ongoing losses, cash sufficient only into Q2 2026, a going concern doubt from auditors, and recent Nasdaq bid price non-compliance (below $1.00 since Feb 2026, deadline Aug 24, 2026), risking delisting despite prior equity compliance. Additional risks include dilution from up to $16M more securities issuable, high stock volatility (low $0.314 to high $4.85 over past year), and potential penny stock restrictions.

• ·Current cash on hand sufficient to fund operations into Q2 2026.
• ·Nasdaq compliance history: Regained stockholders’ equity compliance Nov 14, 2024 (as of Sep 30, 2024); bid price compliance Dec 20, 2024; non-compliant equity as of Sep 30, 2025 but compliant post-Nov 14, 2025 raise; bid price non-compliant notice Feb 25, 2026.
• ·Selling Securityholders bear their own underwriting discounts, commissions, and expenses; company bears registration costs.
• ·Authorized to issue preferred stock series with customizable terms via Board resolution.

09-04-2026

Vishay Precision Group, Inc. (VPG) issued a DEF 14A proxy statement dated April 9, 2026, for its 2026 Annual Meeting of Stockholders on May 19, 2026, at 9:00 a.m. local time in a virtual format. Stockholders of record as of March 23, 2026, will vote on three proposals: election of six directors by plurality, ratification of Brightman Almagor Zohar & Co. (Deloitte network) as independent auditors for the year ending December 31, 2026, and advisory approval of named executive officer compensation, with the Board recommending FOR all. Outstanding shares include 12,274,522 of common stock (1 vote each) and 1,022,887 of Class B common stock (10 votes each); quorum requires a majority of votes represented.

• ·Voting methods: Internet (www.proxyvote.com), phone (1-800-690-6903), mail, or virtually at meeting using 16-digit control number.
• ·Broker non-votes counted for quorum but not votes cast; no discretionary broker voting on director election or say-on-pay.
• ·Stockholder proposals/nominations for 2027 annual meeting referenced (page 40).
• ·Virtual meeting access: www.virtualshareholdermeeting.com/VPG2026.

09-04-2026

Artificial Intelligence Technology Solutions, Inc. (AITX) filed a Form 8-K on April 9, 2026, under Items 8.01 and 9.01, announcing the issuance of a press release titled 'AITX's RAD-R Unveils New radcam.ai Built Around the RADCam Experience,' attached as Exhibit 99.1. The information is furnished and not deemed filed for liability purposes. No financial metrics or period comparisons are reported.

• ·Filing is not intended to satisfy other filing obligations under Rule 425, 14a-12, 14d-2(b), or 13e-4(c).
• ·Registrant is incorporated in Nevada with CIK 0001498148 and EIN 27-2343603.
• ·Principal executive offices at 10800 Galaxie Avenue, Ferndale, Michigan 48220.

09-04-2026

On April 8, 2026, IDEAYA Biosciences, Inc. entered into a clinical collaboration agreement with AstraZeneca plc to evaluate IDE849, a potential first-in-class DLL3 TOP1 antibody-drug conjugate, in combination with AstraZeneca's Imfinzi (durvalumab) for extensive-stage small cell lung cancer (SCLC). IDEAYA will sponsor the clinical combination study, with AstraZeneca supplying Imfinzi, as part of advancing a multi-site global Phase 1 trial for IDE849 in DLL3 upregulated solid tumors including SCLC, neuroendocrine carcinomas (NECs), neuroendocrine tumors (NETs), and melanoma.

• ·Trial enrollment in North America, Europe, Australia, South America, and Asia.
• ·DLL3 upregulated in SCLC, NECs, NETs, non-small cell lung cancer, and melanoma.
• ·DLL3 has limited extracellular expression in normal tissues.

09-04-2026

Six Flags Entertainment Corporation announced that its subsidiary, Six Flags America Property Corporation, entered into a purchase agreement to sell certain real property in Prince George’s County, Maryland, to a joint venture between 35V (co-founded by Kevin Durant and Rich Kleiman) and TPA Group. The company plans to use net proceeds from the transaction to pay down debt obligations. The deal remains subject to buyer diligence and other closing conditions.

• ·The information under Item 7.01 is not deemed 'filed' for purposes of Section 18 of the Exchange Act.
• ·Registrant’s principal executive offices: 8701 Red Oak Blvd., Charlotte, North Carolina 28217.

09-04-2026

News Corporation filed an 8-K disclosing information provided to the Australian Securities Exchange (ASX) regarding its ongoing $1 billion stock repurchase program for Class A (NWSA) and Class B (NWS) common stock. The program authorizes repurchases of up to $1 billion in aggregate, with daily disclosures to ASX as required. Exhibits 99.1 and 99.2 contain the specific ASX disclosures on their respective dates; no new transactions or program changes are detailed.

• ·Date of earliest event reported: April 8, 2026
• ·Filing date: April 9, 2026
• ·Principal executive offices: 1211 Avenue of the Americas, New York, New York 10036
• ·Registrant not an emerging growth company

09-04-2026

The Board of abrdn National Municipal Income Fund (VFL) is proposing a reorganization into MFS Municipal Income Fund (MFM) to broaden VFL's investment mandate by removing the current 20% limit on High Yield municipal bonds, allowing expected allocations of 30-50% depending on market conditions, which could enhance income, distributions, and risk-adjusted returns through a larger, more liquid fund with lower expenses. This change weighs a modest increase in credit risk—evidenced by MFM's lower AAA exposure (16% vs. VFL's 45%) and higher Not Rated (40% vs. 19%) and CCC/below (25% vs. 14%) holdings as of 12/31/25—against benefits like improved diversification and higher yields. Even if the reorganization fails, the Board plans to broaden VFL's mandate similarly.

• ·Data sourced from Fund Factsheets as of 12/31/25
• ·Aberdeen expects to manage with High Yield allocations of 30-50% depending on market conditions, whether reorganization occurs or not
• ·Historical analysis shows municipal High Yield default rates lower than comparable corporates

09-04-2026

Abra Financial Holdings, Inc.'s CEO Bill Barhydt appeared on Yahoo Finance TV on April 8, 2026, discussing the $750 million SPAC merger with New Providence Acquisition Corp. III (announced via Business Combination Agreement dated March 16, 2026) to list on NASDAQ under ticker ABRX, highlighting benefits like building trust as a public RIA and advancing asset tokenization and DeFi lending. He expressed bullish views on Bitcoin, citing rising global liquidity and a 65% chance of reaching all-time highs near $100K by year-end. The filing includes standard forward-looking disclaimers and risks such as transaction failure or shareholder approval issues.

• ·Business Combination Agreement dated March 16, 2026
• ·Interview aired April 8, 2026 at 4:30 pm ET
• ·Bitcoin current price referenced as $71,000 during interview
• ·Post-merger NASDAQ ticker: ABRX
• ·Upcoming SEC Form S-4 Registration Statement including proxy statement/prospectus

09-04-2026

New Providence Acquisition Corp. III filed a Form 425 disclosing a Yahoo Finance TV interview with Abra Financial Holdings, Inc. CEO Bill Barhydt on April 8, 2026, discussing the $750 million SPAC business combination announced March 16, 2026, to list Abra on NASDAQ under ticker ABRX. Barhydt expressed optimism on Bitcoin's potential to hit all-time highs amid rising global liquidity, while highlighting Abra's DeFi lending advantages over private credit, noting past counterparty risks in centralized lending have been mitigated. The filing includes standard forward-looking statement disclaimers and risks related to the merger completion.

• ·Business Combination Agreement dated March 16, 2026, between Abra Financial Holdings, Inc., New Providence Acquisition Corp. III, and Aether Merger Sub I, Corp.
• ·Upcoming Registration Statement on Form S-4 with definitive proxy statement/prospectus.
• ·Post-merger ticker: ABRX on NASDAQ.
• ·Abra operates as a registered investment advisor (RIA).

09-04-2026

EHRLICH Financial Group filed Form 13F-HR on April 9, 2026, disclosing its institutional equity holdings as of March 31, 2026, comprising 112 positions with a total market value of $174,015,055,000. Top holdings include BlackRock ETF Trust iShares US Equity (CUSIP 09290C103) valued at $7,877,897,000 (135,406 shares), SPDR Index Shares Funds State Street S&P (CUSIP 78463X509) at $4,496,057,000 (95,844 shares), and iShares Trust S&P 500 Growth ETF (CUSIP 464287309) at $4,439,865,000 (39,253 shares). No prior period data or changes are provided in the filing.

• ·Filing as of date: April 9, 2026
• ·Conformed period of report: March 31, 2026
• ·Date as of change: April 8, 2026
• ·All holdings reported as sole voting/dispositive power (SH SOLE)

09-04-2026

LifeGuide Financial Advisors, LLC disclosed total holdings of $312,728,791 across 46 positions, all held on a sole discretionary basis, as of March 31, 2026. Largest positions include Dimensional ETF Trust Global Real Estate ETF ($66,705,702), Schwab Strategic Trust US TIPS ETF ($51,664,331), and Dimensional ETF Trust US Core Equity 2 ($29,387,908). The filing was submitted on April 9, 2026, and signed by David Lutz, Chief Compliance Officer.

• ·All 46 positions held as sole discretionary with no shared or other manager discretion.
• ·Address: 400 W. Main St., Mechanicsburg, PA 17055.
• ·Filing covers period ending March 31, 2026.

09-04-2026

Ellington Financial Inc. filed a DEFA14A Definitive Additional Proxy Materials on April 09, 2026, as part of proxy solicitation under Schedule 14A. The filing consists primarily of boilerplate form details with no fee required and no specific proposals, financial data, or substantive content provided. This appears to supplement prior proxy materials without introducing new investor-relevant information.

09-04-2026

Forte Biosciences, Inc. (Nasdaq: FBRX) announced the pricing of a $150 million public offering of 5,709,936 shares of common stock at $26.27 per share, with underwriters granted a 30-day option to purchase up to 856,490 additional shares. Gross proceeds are expected to be approximately $150 million before deducting underwriting discounts, commissions, and other expenses, to be used for working capital, funding clinical development of FB102, and other research activities. The offering is expected to close on or about April 10, 2026, subject to customary conditions.

• ·Guggenheim Securities and Barclays acting as joint book-running managers.
• ·Offering pursuant to Registration Statement on Form S-3 (File No. 333-286226).
• ·Intended use of net proceeds includes working capital and general corporate purposes.

09-04-2026

CoreWeave, Inc. entered into a new order form with Meta Platforms, Inc. on March 31, 2026, under their existing Master Services Agreement dated December 10, 2023, securing Meta's commitment to pay approximately $21 billion for cloud computing capacity. This includes access to new capacity through December 20, 2032, and the exercise of an existing option for additional capacity through April 10, 2032. The agreement contains standard termination rights for cause, representations, warranties, indemnification, and liability limitations.

• ·Press release furnished as Exhibit 99.1 and not deemed 'filed' under Section 18 of the Exchange Act.
• ·MSA full text available in CoreWeave's 8-K filed September 30, 2025 as Exhibit 10.1.

09-04-2026

On April 9, 2026, Zeo ScientifiX, Inc. (ZEO) entered into a Memorandum of Understanding (MOU) with Regen Therapy to establish an exclusive scientific and biologics strategic collaboration. Pursuant to the MOU, ZEO is positioned as the core supplier of advanced biologic therapeutics to be incorporated into Regen’s next-generation regenerative offerings on its clinical platform. The press release detailing the announcement is included as Exhibit 99.1.

• ·Filing includes Exhibit 99.1: Press Release dated April 9, 2026
• ·ZEO’s principal executive offices: 3321 College Avenue, Suite 246, Davie, Florida 33314

09-04-2026

First Real Estate Investment Trust of New Jersey, Inc. (FREVS) entered into a Purchase and Sale Agreement on April 8, 2026, with an affiliate of Regency Centers Corporation to sell 100% of its ownership interests in the Franklin Crossing shopping center for $27,000,000. The agreement includes an initial $1,000,000 escrow deposit refundable during a 30-day due diligence period ending May 8, 2026, and an additional non-refundable $1,000,000 deposit thereafter, with closing expected in Q3 2026 but no later than August 15, 2026. The Board unanimously approved the transaction, which has no financing contingency.

• ·Franklin Crossing located at 814-860 Franklin Avenue, Franklin Lakes, New Jersey
• ·No financing contingency in the agreement
• ·Customary representations, warranties, indemnity provisions, and termination rights apply

09-04-2026

DHJJ Financial Advisors, Ltd. filed its 13F-HR on April 9, 2026, reporting institutional holdings as of March 31, 2026, consisting of 1081 sole discretionary positions in equities and ETFs with no reported changes, puts, or calls. Top holdings include Dimensional ETF Trust International Core Equity Market ETF at $4,161,392,000, First Trust Exchange Traded FD Rising Dividend Achievers at $3,905,498,000, Apple Inc. at $3,875,224,000, and Caterpillar Inc. at $3,229,437,000. The filing provides a snapshot of the firm's diversified portfolio without period-over-period comparisons.

• ·Filer CIK: 0001844716
• ·Business address: 184 Shuman Boulevard, Suite 200, Naperville, IL 60563
• ·All positions reported as sole discretionary shared ownership with zero puts and zero calls

09-04-2026

The Federal Home Loan Bank of San Francisco reported the creation of direct financial obligations via two consolidated obligation bonds for which it is the primary obligor, each with a par value of $10,000,000, issued on trade dates April 6 and April 7, 2026, settling April 9, 2026, and maturing April 9, 2031. The bonds feature fixed rates of 4.250% (European callable style, next call April 9, 2027) and 4.500% (Bermudan callable style, next call October 9, 2026), as part of routine capital markets funding backed jointly by the eleven Federal Home Loan Banks. No period-over-period comparisons or performance metrics were provided, reflecting standard debt issuance activity.

• ·First bond (CUSIP 3130BAAC): Next Pay Date October 9, 2026; Rate Type Fixed Constant
• ·Second bond (CUSIP 3130BA7F): Next Pay Date October 9, 2026; Rate Type Fixed Constant
• ·Consolidated obligations are joint and several obligations of the eleven Federal Home Loan Banks, not guaranteed by the U.S. government
• ·Schedule A excludes discount notes with maturity of one year or less issued in ordinary course

09-04-2026

CRA Financial Services, LLC filed its 13F-HR on April 9, 2026, reporting holdings as of March 31, 2026, with a total portfolio value of $770,099,080 across 296 positions, all held as sole voting authority. Top holdings include Apple Inc. COM (200502 shares valued at $50885478), NVIDIA Corporation COM (132431 shares at $23095891), Amazon.com Inc. COM (136170 shares at $28360190), Alphabet Inc. Cap Stk Cl A (68185 shares at $19607412), and Microsoft Corp. COM (42382 shares at $15688438). The filing discloses a diversified portfolio heavy in technology, ETFs, and broad market funds with no reported changes summarized.

• ·All 296 positions held with sole voting authority (SH SOLE).
• ·Filer CIK: 0001765594, based in Northfield, NJ.
• ·No additions, deletions, or changes summarized in filing header (indicated by '0').

09-04-2026

The Federal Home Loan Bank of Cincinnati filed an 8-K under Item 2.03 disclosing the creation of a direct financial obligation through the commitment to issue a Consolidated Bond with a par value of $25,000,000. The bond, traded on April 6, 2026, has a fixed constant rate of 4.400%, matures on April 17, 2029, and features Optional Principal Redemption (Bermudan style) with the next call date on July 17, 2026. No other comparative financial metrics or performance changes were reported.

• ·Trade Date: April 6, 2026
• ·Settlement Date: April 17, 2026
• ·Next Pay Date: October 17, 2026
• ·CUSIP: 3130BAB2
• ·Schedule A excludes Consolidated Discount Notes due to short-term maturities (max 360 days) and does not reflect derivatives, total outstanding obligations, or GAAP adjustments

09-04-2026

On April 6, 2026, Richard E. Byrd, Executive Vice President and President of Becton Dickinson and Company's (BD) Interventional segment, informed the company of his intention to retire and will remain in his role through June 2026. BD intends to name a successor prior to his retirement date. A press release regarding this matter was issued on April 9, 2026, and furnished as Exhibit 99.1.

• ·Filing reported under Items 5.02, 7.01, and 9.01 of Form 8-K.

09-04-2026

Texas Pacific Land Corporation issued a press release on April 9, 2026, announcing the passing of Murray Stahl, a member of its Board of Directors. The disclosure was made pursuant to Regulation FD and furnished as Exhibit 99.1. No additional financial or operational impacts were detailed in the filing.

• ·Filing includes Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits).
• ·Information in Item 7.01 and Exhibit 99.1 is not deemed 'filed' under Section 18 of the Exchange Act.

09-04-2026

LiveWire Group, Inc. filed its definitive 2026 Proxy Statement (DEF 14A) on April 9, 2026, for the virtual annual meeting on May 21, 2026, at 4:30 p.m. CT, to elect seven director nominees and ratify KPMG LLP as independent auditors for the fiscal year ending December 31, 2026. The Chairman and CEO letter highlights 2025 progress, including maintaining the #1 position in U.S. on-road electric motorcycle retail sales (per MIC data for December 2025), international expansion into new European markets, and product introductions like S2 Alpinista, STACYC, and S4 Honcho. As of the record date March 23, 2026, 204,761,830 shares of common stock were outstanding.

• ·Annual meeting held virtually only via www.virtualshareholdermeeting.com/LVWR2026; login starts at 4:15 p.m. CT.
• ·Proxy materials available at www.proxyvote.com; printed copies requested by May 7, 2026.
• ·Board recommends voting 'For' all seven director nominees and 'For' KPMG ratification.

09-04-2026

Tilly's, Inc. reported FY2026 net sales of $553,585 thousand, down 2.8% YoY from $569,453 thousand due to store closures (net stores down from 240 to 223), though comparable store sales turned positive at +0.3% versus -8.0% in FY2025. Gross profit rose 9.9% to $164,467 thousand with margins expanding to 29.7% from 26.3%, narrowing the operating loss to $19,340 thousand from $49,849 thousand and net loss to $17,452 thousand from $46,229 thousand. However, selling, general and administrative expenses remained high at 33.2% of sales, total assets declined to $310,760 thousand, and stockholders' equity fell to $85,142 thousand.

• ·Average net sales per brick-and-mortar store FY2026: $1,829 thousand (up from $1,791 thousand in FY2025)
• ·E-com revenues FY2026: $122,456 thousand (22.1% of net sales, flat YoY)
• ·Merchandise inventories as of Jan 31, 2026: $61,692 thousand (down from $69,178 thousand)
• ·Net cash from investing activities FY2026: $21,159 thousand
• ·Rent expense, related party consistent at ~$3,727 thousand in cost of goods sold across periods

09-04-2026

ProMIS Neurosciences Inc. filed definitive additional proxy materials (DEFA14A) for its 2026 Annual Meeting scheduled virtually on May 20, 2026 at 10:30 AM ET. Key proposals include the election of seven directors (all board-recommended FOR), ratification of Baker Tilly US, LLP as independent auditors for the fiscal year ending December 31, 2026 (FOR), and approval of an amendment to the 2025 Stock Option and Incentive Plan (FOR). No financial metrics or performance data are disclosed in this filing.

• ·Filing date: April 09, 2026
• ·Vote deadline: May 19, 2026 11:59 PM ET
• ·Proxy materials request deadline: May 6, 2026
• ·Virtual meeting URL: www.virtualshareholdermeeting.com/PMN2026
• ·Company address: ONE BROADWAY, SUITE 1400 CAMBRIDGE, MA 02142 USA

09-04-2026

New York University filed Form 13F-HR on April 9, 2026, reporting its equity holdings as of March 31, 2026. The filing discloses a single holding: 55,741 shares of iShares MSCI Emerging Markets ETF (CUSIP: 464287234) valued at $3,165,531, held with sole voting authority. No prior period comparisons or changes in holdings are detailed in the filing.

• ·Filing covers period ended March 31, 2026
• ·CUSIP of holding: 464287234

09-04-2026

Pacific Gas and Electric Company filed a DEFA14A on April 09, 2026, consisting of definitive additional proxy materials under Schedule 14A (Amendment No. ). The filing is designated as a Preliminary Proxy Statement, confidential for Commission use only per Rule 14a-6(e)(2), with no filing fee required.

• ·Filed by the Registrant (not a third party).
• ·Soliciting Material under §240.14a-12.

09-04-2026

Wintrust Financial Corporation filed Definitive Additional Proxy Materials (DEFA14A) on April 09, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing is marked as soliciting material under §240.14a-12 with no fee required. No substantive proxy details, financial data, or voting matters are included in the provided content.

• ·Filing Type: DEFA14A (Definitive Additional Materials)
• ·Filed by the Registrant

09-04-2026

Sixth Street Specialty Lending, Inc. (TSLX) is seeking shareholder approval via proxy statement to issue up to 25% of its then-outstanding common stock below NAV per share during a one-year period, with no limit on the discount level or number of offerings. Hypothetical examples illustrate potential NAV dilution for non-participating stockholders ranging from 0.26% (5% offering at 5% discount) to 5.02% (25% offering at 25% discount), while participating stockholders may experience less dilution or slight accretion depending on participation level. The proposal highlights risks including immediate NAV reduction, decreased earnings/assets participation, and potential market price decline, with maximum dilution limited to 20% of NAV per offering at par value.

• ·Maximum shares issuable below NAV limited to 25% of then-outstanding common stock per offering.
• ·Hypothetical net proceeds per share: $16.13 (Ex1), $15.28 (Ex2), $13.58 (Ex3), $12.74 (Ex4).
• ·Public offering prices: $16.09 (Ex1), $14.30 (Ex2), $13.41 (Ex3).
• ·No subscription, preferential, or preemptive rights for existing stockholders.
• ·Filing date: April 09, 2026.

09-04-2026

Jackson Financial Inc. (NYSE: JXN) announced on April 9, 2026, the appointment of Chris Raub as President and Chief Executive Officer of PPM America, Inc., its indirect wholly-owned subsidiary. Raub, with 27 years of experience at PPM and Jackson including prior roles as President of Jackson National Life Insurance Company and Chief Risk Officer, will oversee PPM's executive team to deliver investment performance for clients including Jackson's general account assets. PPM manages $93.73 billion in assets under management as of December 31, 2025.

• ·PPM America offers investment capabilities in public fixed income, commercial real estate debt, private and structured credit, private equity, and CLO management.
• ·AUM includes committed but unfunded capital for PPM’s private equity and commercial real estate businesses, as well as securities issued by PPM CLO vehicles and underlying collateral assets.

09-04-2026

BRC Group Holdings, Inc. (formerly B. Riley Financial, Inc.) has issued a proxy statement for its 2026 Annual Meeting of Stockholders, to be held virtually on May 19, 2026 at 8:00 a.m. Pacific Time. Key proposals include electing seven directors for a one-year term, ratifying BDO USA, P.C. as independent registered public accounting firm for the fiscal year ending December 31, 2026, and an advisory vote to approve named executive officer compensation. The record date is March 26, 2026, with 34,798,366 shares of common stock outstanding held by 131 stockholders of record.

• ·Annual Meeting registration deadline: 8:59 p.m. Pacific Time on May 18, 2026 at https://web.viewproxy.com/BRC/2026
• ·Voting deadlines: Internet and telephone by 8:59 p.m. PT on May 18, 2026
• ·Company address: 11100 Santa Monica Boulevard, Suite 800, Los Angeles, CA 90025; Phone: (310) 966-1444
• ·Fiscal year end: December 31

09-04-2026

Tilia Fiduciary Partners, Inc. filed a 13F-HR report disclosing $181,990,637 in total market value across 115 equity positions as of March 31, 2026. Top holdings include Amazon.com Inc. ($2,235,987), Powershares QQQ Trust ($877,117), Johnson & Johnson ($735,142), Take-Two Interactive Software ($215,275), and Williams Sonoma Inc. ($1,174,222). No period-over-period changes are provided in the filing.

• ·Filing covers period ending March 31, 2026, filed April 9, 2026.
• ·All positions reported with sole voting power (SOLE).

09-04-2026

Bogota Financial Corp. issued a definitive proxy statement for its 2026 annual stockholder meeting on May 14, 2026, at the Teaneck Marriott at Glenpointe, Teaneck, NJ, covering the election of two directors for three-year terms, ratification of S.R. Snodgrass, P.C. as independent auditors for the year ending December 31, 2026, an advisory vote on named executive officer compensation, and an advisory vote on the frequency of future say-on-pay votes (Board recommends one year). The record date is March 20, 2026, with 12,919,366 common shares outstanding, of which Bogota Financial, MHC holds a controlling majority of 8,504,556 shares, ensuring quorum and determining vote outcomes regardless of public participation. Public stockholders hold 4,414,810 shares, but MHC ownership limits their influence on results.

• ·Quorum requires majority of outstanding shares entitled to vote; directors elected by plurality, other items by majority of votes cast.
• ·Broker non-votes and abstentions have no effect on outcomes; MHC votes ensure passage of Board-recommended positions.
• ·Proxy voting deadline via Internet/telephone: 11:59 p.m. ET on May 13, 2026; materials mailed starting April 9, 2026.
• ·Record holders >10% ownership (excluding MHC) limited to 10% voting rights per Articles of Incorporation.

09-04-2026

Spruce Biosciences, Inc. (SPRB) has filed definitive additional proxy materials (DEFA14A) for its 2026 Annual Meeting of Stockholders, scheduled virtually on May 21, 2026 at 10:00 A.M. Pacific Time. Key proposals include electing three Class III directors—Michael Grey, Camilla V. Simpson, M.Sc., and Javier Szwarcberg, M.D., MPH—to serve until the 2029 annual meeting; ratifying BDO USA, P.C. as the independent auditor for the fiscal year ending December 31, 2026; advisory approval of named executive officer compensation; and advisory vote on the frequency of future say-on-pay votes. Shareholders must vote by May 20, 2026, 11:59 P.M. Eastern Time, with proxy materials available online at www.ProxyVote.com.

• ·Meeting location: www.virtualshareholdermeeting.com/SPRB2026
• ·Material request deadline: May 7, 2026
• ·Company address: 611 Gateway Boulevard, Suite 740, South San Francisco, CA 94080

09-04-2026

STEWARDSHIP CONCEPTS FINANCIAL SERVICES LLC filed its 13F-HR on April 9, 2026, disclosing total holdings valued at $127,633,859 across 62 positions as of March 31, 2026. Top holdings include SCHWAB STRATEGIC TR US DIVIDEND EQ ($9,244,149), CAPITAL GROUP DIVIDEND VALUE SHS ($8,888,690), SCHWAB STRATEGIC TR US LCAP GR ETF ($8,143,175), and CAPITAL GROUP GROWTH ETF SHS ($7,329,473). All positions are held on a sole discretionary basis with no other managers reported.

• ·Filing period end date: March 31, 2026
• ·Business address: 7307 N Division St, Ste 205, Spokane, WA 99208
• ·No put or call options reported (0 0)

09-04-2026

Science Applications International Corp (SAIC) appointed Paul Eremenko and Admiral Michael Rogers, USN Retired, as new members of its Board of Directors effective April 8, 2026, increasing the board size from eleven to thirteen members; both will serve on the Audit Committee and Technology Committee until the 2026 Annual Meeting. Mr. Eremenko brings expertise in AI, aerospace, and advanced engineering from roles at P-1 AI, Universal Hydrogen, UTC/RTX, Airbus, Google, and DARPA. Adm. Rogers offers deep experience in cybersecurity, intelligence, and national security from his tenure as Director of the NSA and Commander of U.S. Cyber Command.

• ·New directors entitled to standard non-employee director cash and equity compensation, pro-rated to 2026 Annual Meeting, and participation in Deferred Compensation Plan.
• ·No arrangements or understandings pursuant to which appointees were selected.
• ·No relationships or related transactions required to be reported under Item 404(a) of Regulation S-K.